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Abstract
Fumonisin Bjis a mycotoxin produced by fungi of the genus Fusarium, common pathogens of corn and other grain plants.
r]:»xic effects associated with fumonisin Bjinclude equine leukoencephalomacia, porcine pulmonary edema, rat renal carcino-
r ,a, and murine hepatocellular carcinoma. Increased risk for esophageal cancer inhumans has been epidemiologically asso-
c ated with consumption of corn contaminated with Fusarium, suggesting that fumonisin Bjmay be involved. The biological
effects of fumonisin Bjexposure result primarily from disruption of de novo sphingolipid biosynthesis via inhibition ofceramide
s/nthase. Exposure of animals or cultured cells to fumonisin Bjresults inthe characteristic accumulation of sphinganine, a toxic
sphingolipid intermediate, concomitant with depletion of essential complex sphingolipids.
Ceramide synthase has not been purified to homogeniety and characterized. We prepared crude ceramide synthase from
detergent-extracted rat liver homogenates using PEG-precipitation and cation exchange chromatography. Ceramide synthase
activity was then sequestered, using fumonisin Bj covalently coupled to POROS-NH# particles, and eluted selectively. The
observed 119-fold enrichment in specific activity demonstrates the utilityof fumonisin-POROS affinitychromatography in the
purification of ceramide synthase.
Introduction
Fumonisin Bj (FBI) is a toxinproduced by members of
le fungal genus Fusarium (Gelderblom et al., 1988; Thiel et
., 1991). Fusarium moniliforme, a common source of FBI, is
typical fungal contaminant of economically important
ereal crops. The infection of corn with Fusarium, particu-
arly problematic after periods ofdrought-induced stress fol-
owed by warm, moist weather, produces ear rot and stalk
t diseases that can be devastating to crop productivity
chaafsma et al., 1993).
I
FBI produces diverse pathological effects in animals
nsuming FBI-contaminated food. FBI causes equine
ikoencephalomacia inhorses (Marasas et al., 1988), pul-
anary edema in swine (Harrison et al., 1990), immuno-
ppression in turkey poults (Liet al., 2000), and renal tox-
ty in rabbits (Gumprecht et al., 1995; Bucci et al., 1998).
'o-year FBI exposure studies in rodents, funded by the
itional Toxicology Project and performed at the National
inter for Toxicological Research, were recently complet-. These studies demonstrated that dietary exposure to•1produced hepatic carcinoma in female B6C3Fj/NCTR
ce and renal carcinoma in male Fischer 344/NCTR rats
oward et al., 1999). Epidemiological studies have associ-
;d the consumption of corn contaminated with Fusarium
th esophageal cancer in humans (Marasas et al., 1988;
luand Li,1994).
tDisruption of sphingolipid biosynthesis via inhibition ofmide synthase appears to be the principal biochemical:t of exposure to FBI (reviewed in Merrill et al., 1995).
FB1 is structurally similar to the sphingoid base substrates of
the ceramide synthase catalyzed reaction (Fig. 1).
Sphinganine, an acyl group acceptor substrate for the
ceramide synthase catalyzed reaction, accumulates rapidly
in cultured cells or tissues exposed to FBI. Ceramides can
be liberated from complex sphingolipids via enzymatic
hydrolysis or produced via de novobiosynthesis through the
ceramide synthase catalyzed reaction. Increased ceramide
levels produced by either mechanism have been associated
with apoptosis (Mathias et al., 1998). Blocking the ceramide
synthase catalyzed N-acylation of sphinganine by FB1 also
causes depletion of complex sphingolipid pools, including:
dihydroceramides, ceramides, glucosylceramides, sphin-
gomyelin, gangliosides, cerebrosides, and sulfatides.
Maintenance of complex sphingolipid pools are important
for cell survival and depletion of complex sphingolipids
contributes to FBI toxicity (Yoo et al., 1996; Tolleson et al.,
1999).
The regulation of ceramide synthase catalytic activity
must be critical for cell survival because it affects the con-
centrations of sphingolipid mediators that influence cell sur-
vival and death processes. Furthermore, signal transduction
pathways regulating ceramide synthase gene expression and
its enzymatic activity may exert an effect on the homeostat-
ic balance of strategic sphingolipids. The first step in
understanding the biochemical nature of ceramide biosyn-
thesis is the isolation of the active enzyme. Several groups
have reported the partial purification of ceramide synthase,
but none have been successful in completing its isolation to
homogeniety. We endeavored to test a FBI affinity chro-
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matography column for isolating fumonisin-binding pro-
teins expected to be present in rat liver. We previously dis-
covered that our FBI affinity column sequestered rat liver
argininosuccinate synthetase from rat liver extracts and that
both rat liver and recombinant human argininosuccinate
synthetases are inhibited by FBI invitro(Ki'=6 mMand 35
mM for human and rat liver argininosuccinate synthetase,
respectively; Jenkins et al., 2000). Although ceramide syn-
thase is believed to represent the most significant target for
the biological action of FBI, other enzyme systems are
affected by FBI. Fukuda et al. (1996) showed that FBI
inhibits recombinant rat protein phosphatase 5 (PP5) with
an IC50 of 80 |iMand PPly2, PP2A, PP2B, and PP2C with
IC50 values 300-1000 uM. PP5 is reportedly expressed in
many tissues, including hepatocellular carcinoma cell lines,
but itispoorly expressed innormal liver samples and would
not be expected in the sample used in this study (Shirato et
al., 2000). We predicted that ceramide synthase or other
FBI-binding proteins could be recovered from rat liver
extracts using FB1 affinity chromatography.
Materials and methods
Sample Preparation.--^ sample processing and chn >-
matographic procedures were performed at 4°C except
where indicated. Rat liver extract was prepared by mechai i-
ical distruption (Polytron, Brinkmann Instrumen s
Company, Westbury, NY) of frozen rat livers in 50 mM
sodium phosphate buffer, pH 6.5 containing 10 mMEDTA,
150 mM sodium chloride, and 2% Triton X-100™ followed
by 30 min incubation at 0°C. Cellular debris and other
insoluble matter was removed by centrifugation for 15 mii
at 21,000g. Polyethylene glycol (PEG) was added to 10%
(w/v) to the supernatant and contaminating proteins were
removed from the rat liver detergent extract by precipita-
tion and centrifugation. Ceramide synthase activity was
precipitated by increasing the PEG concentration to 20%.
In some cases rat liver cytosol was prepared by disrupting
rat liver samples in the absence of detergents, then remov-
ingcellular debris and organelles by high speed centrifuga-
tion, adding Triton X100 to 2% and preparing cytosolic 10-
20% PEG fractions. The 10-20% PEG precipitates were
collected by centrifugation and redissolved in 25 mM sodi-
um phosphate buffer, pH 6.5 containing 1 mMEDTA and
2% Triton X-100, and applied to a 5x20 cm SP-Sepharose
strong cation exchange column. Ceramide synthase activity
was eluted from the cation exchange column using an
increasing pH and salt gradient (linear gradient from 0-40%
Buffer B over 120 min; flow rate 3.0 mL/min; Buffer A:25
mM sodium phosphate, 1mMEDTA,0.2% Brij-35, pH6.5;
Buffer B: 25 mM sodium phosphate, ImM EDTA, 0.2%
Brij-35, 2.0 Msodium chloride, pH 7.5). Fractions contain-
ing ceramide synthase activity were pooled and dialyzed
twice against 50 volumes of 50 mM sodium phosphate, 1
mMEDTA,0.2% Brij-35, pH 6.8.
POROS-FB1 Affinity Chromatography. -The POROS
FBI affinity matrix was prepared by coupling FBI tricar-
byllate groups to free primary amine groups on 20 um
POROS-NH™ particles (Perceptive Biosystems, Foster City,
CA), as previously described (Newkirk etal., 1998; Jenkins et
al., 2000). A suspension of POROS-FB1 matrix was slurry
packed into a 0.46 cm x 10.0 cm polymer column jacket fit-
ted with 2 |im end frits and installed into a Varian ProStar
biocompatible HPLC system equipped with a Varian
ProStar variable wavelength UV/Vis detector, a BioRad
Econo Gradient monitor, and a BioRad Model 2128 fraction
collector. Data were collected and processed using
Maclntegrator IISoftware (Varian) and a Macintosh
Quadra personal computer, which also provided control for
the pump units.
The POROS-FB1 affinity column was equilibrated in
dialysis buffer and loaded at 4 mL/min. Ceramide synthase
activity was eluted from the POROS-FB1 column using a
two-step gradient of increasing ionic strength (linear gradi-
ent from 0-25% Buffer B from 0-10 minutes, 25-100% Buffer
Fig. 1. Structures of fumonisin Bj,sphinganine, sphingosine,
and N-palmitoylsphingosine, depicting stereochemical sim-
ilarities.
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g rom 10-15 min; flow rate 4 mL/min; Buffer A:50 mM
s( ium phosphate, 1 mM EDTA, 0.2% Brij-35, pH 6.8;
B fer B: 2.0 Msodium chloride dissolved in Buffer A).
Analytical Procedures.-Protein concentrations were
d ermined using the Pierce BCA Protein Assay Kit with
b /ine serum albumin standards (Pierce Endogen,
R ckford, IL) according to the manufacturer's specifica-
ti is. Denaturing polyacrylamide gel electrophoresis was
p formed using 4-20% gradient Ready Gels (BioRad,
H rcules, CA) with BioSafe Coomassie Stain. Ceramide
s\ ithase activity was measured using the method described
b Hirshberg et al. (1993) and adapted slightly for our use
(jmkins et al., 2000). Assay reactions were performed in50
mM sodium phosphate buffer, pH 6.9. Samples were
desalted prior to activity measurements by three sequential
dilutions (1:10) with cold assay buffer and centrifugal ultra-
filtration at 4°C using Ultrafree 0.5 microconcentrator
devices (10,000 MWCO, Millipore, Bedford, MA).
Desalted samples were incubated with 0.2 uCi [14C]-palmi-
toyl coenzyme A (60 mCi/mmole, NEN, Boston, MA) and
40 (iM D-tfry/Aro-sphingosine (Sigma Chemical Co., St.
Louis, MO) in0.25 mL reactions for 20 min at 37°C. The
reactions were quenched by placing the tubes in an
ice/water bath for 1min prior to extraction. Samples con-
taining polyethylene glycol were extracted twice with 0.5
mL diethyl ether. Allother samples were extracted once
with 0.6 mL 2:1 chloroform/methanol and once with 0.4
mL chloroform. The organic extracts were dried in vacuo,
dissolved in chloroform, and applied to LK5DF silica thin
layer plates (Whatman Inc., Clifton,NJ). Thin layer chro-
matography was performed using 90:7:3
chloroform/methanol/concentrated ammonium hydroxide.
Authentic N-palmitoylsphingosine was included as a refer-
ence standard and visualized by post-run exposure to iodine
vapor. [14C]-N-palmitoylsphingosine reaction products were
quantified by phosphorimagining (Molecular Dynamics
Corporation, Sunnydale, CA) with ImageQuant software.
Iickground reaction
rates for protein-free reactions were
btracted from all measurements. Specific activity values
ire determined by dividing the net amount of ceramide
oduct formed, expressed as volume integration counts, by
e amount of protein added to the reaction.
Results
Ceramide synthase activity was detected in rat liver
detergent extracts and concentrated using polyethylene gly-
col precipitation (Fig. 2A). Prior work in our laboratory
determined that ceramide synthase activity could be detect-
ed in the absence of detergents. However, the addition of
detergents prevented excessive losses of ceramide synthase
through nonspecific association with heterogenous protein
precipitates (data not shown). Alarge amount of extraneous
protein was removed by differential precipitation withPEG,
and the sample volume was reduced (Table 1). Although
the apparent specific activity appeared to be relatively
unchanged following PEG precipitation, the presence of
PEG in these samples may have interfered withenzyme cat-
alyzed reaction. We observed that the specific activity
recovered somewhat after cation exchange chromatography
in the subsequent step (Fig. 2B). Ceramide synthase activity
Fig. 2. Extraction of ceramide synthase activity from rat
liver. (A) Ceramide synthase activity in rat liver fractions
(100 ug protein/reaction) was determined as given in
Materials and Methods. (B) Ceramide synthase activity in
cation exchange chromatography fractions. Aliquots (100
ug/reaction) from 10-20% PEG fraction (load), unretained
fraction, and retained fractions were subjected to ceramide
synthase assay as described inMaterials and Methods. Insets
displayed under plots: [14C]-N-palmitoylsphingosine reac-
tion products quantified by tic and phosphorimaging.
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was retained by the SP-Sepharose column and eluted at 135-
140 min in approximately 0.35 M sodium chloride. UV
spectroscopy of the retained and nonretained fractions (data
not shown) revealed that a large amount of nonproteina-
ceous UV-absorbing material was removed from the redis-
solved 10-20% PEG fraction.
The ceramide synthase activity in the pooled and dia-
lyzed SP-Sepharose fraction was efficiently adsorbed by the
POROS-FBl column and eluted with sodium chloride
whereas most of the extraneous protein was excluded (Fig.
3A-C). Ceramide synthase activity was not detected in the
unretained sample (Fig. 3C). The specific activity of
ceramide synthase eluted from the POROS-FBl column
increased 17-fold relative to the material applied to the col-
umn (Fig. 3C), and the protein recovery indicated a 119-fold
enrichment by this step (Table 1).
Denaturing gel electrophoresis showed that the hetero-
geneity of active samples correlated inversely withincreased
specific activity. The heterogeneity of the most active sam-
ple eluted from the POROS-FBl column was less than that
of rat liver homogenate, 10-20% PEG fractions, or the SP-
Sepharose fractions (Fig. 3D). Several proteins are particu-
larly prominent in the active fractions eluted from the
POROS-FBl column withapparent Mr of 29, 38, 51, and 74
kDa. Prior work inour laboratory resulted in the purifica-
tion of a small quantity of a homogeneous 38 kDa protein
that exhibited ceramide synthase activity (data not shown).
Discussion
Scribney (1966) first described ceramide biosynthesis
(i.e., ceramide synthase) in brain and liver microsomes.
Morell and Radin (1970) determined the acyl group speci-
ficity specificity of ceramide synthase in rat brain extracts.
Later, the presence of ceramide synthase activity in liver
microsomal fractions was confirmed by Narimatsu et al.
(1986) and extended by Mandon et al. (1992) and Hirshberg
et al. (1993) who detected ceramide synthase activity
present on the cytosolic surface of the endoplasmic reticu-
lum. Shimeno et al. (1995, 1998) also observed ceramide
synthase activity in mitochondrial fractions. Studies
performed in our laboratory confirmed that ceramide syn-
thase activity could be detected in both fractions and that
conditions that partially disrupt organelle integrity released
ceramide synthase activity into the soluble, microsome-free
cytosolic fraction. We utilized Triton X-100 as a nondena-
turing detergent to extract ceramide synthase from whole
liver homogenates.
The purification of ceramide synthase has been a daunt-
ing problem for several research groups. Shimeno et al.
(1998) employed anion exchange chromatography followed
by sphingosine affinity chromatography in the partial purifi-
cation of ceramide synthase. Sphingosine was coupled to
the column matrix via its primary amine group, resulting in
Fig. 3. POROS-FBl affinitychromatography. (A) POROS-
FBl chromatogram. Dialyzed fraction from strong cation
exchange chromatography containing crude ceramide syn-
thase activity was applied to 0.46x10 cm POROS-FBl col-
umn and eluted with sodium chloride. (B) Protein levels in
POROS-FBl chromatographic samples. (C) Ceramide syn-
thase activity in POROS-FBl chromatographic samples.
Insets under plots: [14C]-N-palmitoylsphingosine reaction
products quantified by tic and phosphorimaging. (D)
Denaturing polyacrylamide gel electrophoresis of POROS-
FBl chromatographic samples.
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ble 1- Analysis of ceramide synthase isolation scheme
protein protein
volume concentration yield
sample (mL) (mg/mL) (mg)
, ,mogenate fl 596 37.0 22,040
i 10% PEG fraction* 174 70.5 12,300
)-2O°/o PEG fraction* 87 31.9 2,780
: P-Sepharose (unretained)" 331 3.04 1,010
SP-Sepharose (retained) 0 30 16.3 490
POROS-FB1 load* 28 3.10 86.7
POROS-FB1 (unretained)* 83.5 0.60 50.1
POROS-FB1 (retained)* 4 0.18 0.73
tese samples and those presented inFig. 2 are related toprocessing 141 grat liver as described in the Materials and Methodsion.
Kese samples and those presented in Fig. 3 are related to processing 250 grat liver in the absence of detergent and per-ling a high speed centrifugation to remove nuclei, mitochondria, and microsomes prior to PEG precipitation in the pres-iof detergent and SP-Sepharose chromatography. Similar results were obtained with whole liver extracts.
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interactions. The effective concentrations of these substrates
can be lowered through nonspecific adsorption to extrane-
ous proteins in a concentration-dependent manner. Some
investigators presaturate carrier proteins with excess sphin-
ganine (or sphingosine) for inclusion in ceramide synthase
assays in order to prevent removal of free sphinganine by
nonspecific binding. However, this results in an indetermi-
nate amount of free and bound substrate and does not
ensure adequate concentrations of free sphingoid base sub-
strate. Thus, reaction rates observed in ceramide synthase
activity measurements are generally dependent both on the
concentration of the enzyme and the substrate and are only
informative in a qualitative way regarding relative catalytic
activity. The purification of ceramide synthase willeventu-
ally allow accurate determinations of the rate constants of
this enzyme for its substrates and determination of inhibi-
tion constants for FB1 and related molecules.
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